Similar Articles
1351 Advances in computed tomography and magnetic resonance imaging of hepatocellular carcinoma
1352 Molecular imaging and therapy targeting copper metabolism in hepatocellular carcinoma
1353 Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation
1354 Current status and perspectives of immune-based therapies for hepatocellular carcinoma
1355 Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma
1356 Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma
1357 Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents?
1358 Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes
1359 Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma
1360 Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive review
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA